Lv3
230 积分 2022-10-26 加入
Selective Inhibition of NaV1.8 with VX-548 for Acute Pain
2天前
已完结
Discovery of selective NaV1.8 inhibitors based on 5-chloro-2-(4,4-difluoroazepan-1-yl)-6-methyl nicotinamide scaffold for the treatment of pain
2天前
已完结
Gender difference in the pharmacokinetics and metabolism of VX‐548 in rats
2天前
已完结
Protein Degradation in Focus
2天前
已完结
Drug discovery targeting Nav1.8: Structural insights and therapeutic potential
4天前
已完结
Frontiers in Acute Pain Management: Emerging Concepts in Pain Pathways and the Role of VX-548 as a Novel NaV1.8 Inhibitor: A Narrative Review
4天前
已完结
State-dependent inhibition of Nav1.8 channels by VX-150 and VX-548
4天前
已完结
Use-Dependent Relief of Inhibition of Nav1.8 Channels by A-887826
4天前
已完结
Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases
2个月前
已完结
Gender difference in the pharmacokinetics and metabolism of VX‐548 in rats
2个月前
已完结
皖公网安备34019202002308
